LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset - HMS LINCS Database

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells

|<
<<
Previous
Page 40 of 497
Next
>>
>
976 to 1000 of 12420 records
per page:

Cell	Small Molecule	Small Mol Concentration	Small Mol Conc Unit	LJP Library Plate	Replicate	Assay Well	Timepoint	Timepoint Unit	Total Cell Count Before Treatment	Total Cell Count After Treatment	Total Control Cell Count	Relative Cell Count	Relative Growth Rate After Treatment
BT-20	Selumetinib	0.37	uM	LJP6	1	M10	72	hr	1657	5840	5505	1.0607	1.0869
BT-20	Selumetinib	0.37	uM	LJP6	2	M10	72	hr	1657	6086	5505	1.1054	1.1508
BT-20	Selumetinib	0.37	uM	LJP6	3	M10	72	hr	1657	5125	5505	0.9309	0.9011
BT-20	Sirolimus	0.37	uM	LJP6	1	L16	72	hr	1657	3713	5505	0.6744	0.5341
BT-20	Sirolimus	0.37	uM	LJP6	2	L16	72	hr	1657	3870	5505	0.7029	0.5749
BT-20	Sirolimus	0.37	uM	LJP6	3	L16	72	hr	1657	3304	5505	0.6001	0.4278
BT-20	Sorafenib	0.37	uM	LJP6	1	B10	72	hr	1657	4639	5505	0.8426	0.7748
BT-20	Sorafenib	0.37	uM	LJP6	2	B10	72	hr	1657	4580	5505	0.8319	0.7594
BT-20	Sorafenib	0.37	uM	LJP6	3	B10	72	hr	1657	5322	5505	0.9666	0.9523
BT-20	SU11274	0.37	uM	LJP5	1	J10	72	hr	1657	5300	5505	0.9626	0.9466
BT-20	SU11274	0.37	uM	LJP5	2	J10	72	hr	1657	5476	5505	0.9946	0.9923
BT-20	SU11274	0.37	uM	LJP5	3	J10	72	hr	1657	5547	5505	1.0075	1.0107
BT-20	Fedratinib	0.37	uM	LJP5	1	L04	72	hr	1657	5119	5505	0.9298	0.8995
BT-20	Fedratinib	0.37	uM	LJP5	2	L04	72	hr	1657	5476	5505	0.9946	0.9923
BT-20	Fedratinib	0.37	uM	LJP5	3	L04	72	hr	1657	5245	5505	0.9527	0.9323
BT-20	TGX221	0.37	uM	LJP5	1	H22	72	hr	1657	5538	5505	1.0059	1.0084
BT-20	TGX221	0.37	uM	LJP5	2	H22	72	hr	1657	5510	5505	1.0008	1.0011
BT-20	TGX221	0.37	uM	LJP5	3	H22	72	hr	1657	5629	5505	1.0224	1.0321
BT-20	Torin1	0.37	uM	LJP6	1	O16	72	hr	1657	1706	5505	0.3099	0.0125
BT-20	Torin1	0.37	uM	LJP6	2	O16	72	hr	1657	1796	5505	0.3262	0.0359
BT-20	Torin1	0.37	uM	LJP6	3	O16	72	hr	1657	1842	5505	0.3346	0.0479
BT-20	Torin2	0.37	uM	LJP5	1	I22	72	hr	1657	1620	5505	0.2942	-0.0098
BT-20	Torin2	0.37	uM	LJP5	2	I22	72	hr	1657	1291	5505	0.2345	-0.0953
BT-20	Torin2	0.37	uM	LJP5	3	I22	72	hr	1657	1744	5505	0.3168	0.0224
BT-20	Tozasertib	0.37	uM	LJP5	1	B16	72	hr	1657	1734	5505	0.3150	0.0198

|<
<<
Previous
Page 40 of 497
Next
>>
>
976 to 1000 of 12420 records
per page:

HMS LINCS Project

LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)